Human Phenotype Ontology 
Grandparent Node:
expand
Behavioral abnormality (HP:0000708)help
Parent Node:
expand
Impairment in personality functioning (HP:0031466)help
..Starting node
..expand
Emotional lability (HP:0000712)help
Term ID: 712
Name: Emotional lability
Synonym: Emotional instability; Mood alterations; Mood changes; Mood lability
Definition: Unstable emotional experiences and frequent mood changes; emotions that are easily aroused, intense, and/or out of proportion to events and circumstances.
Comments:
Reference: HP:0000712
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandAbnormal fear/anxiety-related behavior (HP:0100852) help
..expandAnhedonia (HP:0012154) help
..expandBipolar affective disorder (HP:0007302) help
..expandDepression (HP:0000716) help
..expandDisinhibition (HP:0000734) help
..expandHostility (HP:0031473) help
..expandInappropriate behavior (HP:0000719) help
..expandLow self esteem (HP:0031469) help
..expandNegative affectivity (HP:0031467) help
..expandPersonality disorder (HP:0012075) help
..expandSeparation insecurity (HP:0031468) help
InputHPO IDHPO termDistanceGeneGene id entrezDiseaseIdDiseaseNameDiseaseMIMConceptIDSourceTypical associationHGMD variantsClinVar variantsHGNC IDGeneMIM
 
HPO disease - gene - phenotype typical associations:
HP:0000712HP:0000712Emotional lability0ANG CL E G H283803ORPHA1114483105850
HP:0000712HP:0000712Emotional lability0ANXA11 CL E G H311803ORPHA1305535602572
HP:0000712HP:0000712Emotional lability0ARSA CL E G H410309271ORPHA11140713607574
HP:0000712HP:0000712Emotional lability0ARSA CL E G H410250100Metachromatic leukodystrophy250100C0023522OMIM11140713607574
HP:0000712HP:0000712Emotional lability0ATP1A3 CL E G H478128235Dystonia 12128235C1868681OMIM1993801182350
HP:0000712HP:0000712Emotional lability0ATXN2 CL E G H6311803ORPHA111510555601517
HP:0000712HP:0000712Emotional lability0B4GALNT1 CL E G H2583609195Spastic paraplegia 26609195C1836632OMIM12954117601873
HP:0000712HP:0000712Emotional lability0BCS1L CL E G H617256000Leigh syndrome256000C0023264OMIM14131020603647
HP:0000712HP:0000712Emotional lability0BCS1L CL E G H617124000Mitochondrial complex III deficiency124000C1852372OMIM14131020603647
HP:0000712HP:0000712Emotional lability0C19orf12 CL E G H83636614298Neurodegeneration with brain iron accumulation 4614298C3280371OMIM130725443614297
HP:0000712HP:0000712Emotional lability0C9orf72 CL E G H203228803ORPHA117728337614260
HP:0000712HP:0000712Emotional lability0CASR CL E G H846428Autosomal dominant hypocalcemiaCN228164ORPHA123301514601199
HP:0000712HP:0000712Emotional lability0CCNF CL E G H899803ORPHA11511591600227
HP:0000712HP:0000712Emotional lability0CFAP410 CL E G H755803ORPHA14591260603191
HP:0000712HP:0000712Emotional lability0CHCHD10 CL E G H400916803ORPHA129715559615903
HP:0000712HP:0000712Emotional lability0CHMP2B CL E G H25978803ORPHA116024537609512
HP:0000712HP:0000712Emotional lability0COX10 CL E G H1352256000Leigh syndrome256000C0023264OMIM13562260602125
HP:0000712HP:0000712Emotional lability0COX15 CL E G H1355255241ORPHA13572263603646
HP:0000712HP:0000712Emotional lability0COX15 CL E G H1355256000Leigh syndrome256000C0023264OMIM13572263603646
HP:0000712HP:0000712Emotional lability0CTSF CL E G H8722615362Ceroid lipofuscinosis, neuronal, 13615362C3715049OMIM12182531603539
HP:0000712HP:0000712Emotional lability0DAO CL E G H1610803ORPHA1652671124050
HP:0000712HP:0000712Emotional lability0DCTN1 CL E G H1639803ORPHA110842711601143
HP:0000712HP:0000712Emotional lability0DDC CL E G H1644608643Deficiency of aromatic-L-amino-acid decarboxylase608643C1291564OMIM15032719107930
HP:0000712HP:0000712Emotional lability0ECHS1 CL E G H1892255241ORPHA14313151602292
HP:0000712HP:0000712Emotional lability0EIF2B1 CL E G H1967603896Leukoencephalopathy with vanishing white matter603896C1858991OMIM11923257606686
HP:0000712HP:0000712Emotional lability0EIF2B2 CL E G H8892603896Leukoencephalopathy with vanishing white matter603896C1858991OMIM11903258606454
HP:0000712HP:0000712Emotional lability0EIF2B3 CL E G H8891603896Leukoencephalopathy with vanishing white matter603896C1858991OMIM11813259606273
HP:0000712HP:0000712Emotional lability0EIF2B4 CL E G H8890603896Leukoencephalopathy with vanishing white matter603896C1858991OMIM12333260606687
HP:0000712HP:0000712Emotional lability0EIF2B5 CL E G H8893603896Leukoencephalopathy with vanishing white matter603896C1858991OMIM15793261603945
HP:0000712HP:0000712Emotional lability0ELP1 CL E G H8518223900Familial dysautonomia223900C0013364OMIM117525959603722
HP:0000712HP:0000712Emotional lability0EPHA4 CL E G H2043803ORPHA11933388602188
HP:0000712HP:0000712Emotional lability0ERBB4 CL E G H2066803ORPHA14623432600543
HP:0000712HP:0000712Emotional lability0FIG4 CL E G H9896803ORPHA192616873609390
HP:0000712HP:0000712Emotional lability0FOXRED1 CL E G H55572255241ORPHA132326927613622
HP:0000712HP:0000712Emotional lability0FTL CL E G H2512606159Neuroferritinopathy606159C1853578OMIM11853999134790
HP:0000712HP:0000712Emotional lability0FUS CL E G H2521803ORPHA14744010137070
HP:0000712HP:0000712Emotional lability0GLE1 CL E G H2733803ORPHA14754315603371
HP:0000712HP:0000712Emotional lability0GNA11 CL E G H2767428Autosomal dominant hypocalcemiaCN228164ORPHA12834379139313
HP:0000712HP:0000712Emotional lability0HDAC8 CL E G H558693459ORPHA138113315300269
HP:0000712HP:0000712Emotional lability0HNRNPA1 CL E G H3178803ORPHA1805031164017
HP:0000712HP:0000712Emotional lability0LAS1L CL E G H818873459ORPHA128325726300964
HP:0000712HP:0000712Emotional lability0LAS1L CL E G H81887309585Wilson-Turner X-linked mental retardation syndrome309585C1839736OMIM128325726300964
HP:0000712HP:0000712Emotional lability0LEPR CL E G H3953179494ORPHA12936554601007
HP:0000712HP:0000712Emotional lability0LIPT1 CL E G H51601255241ORPHA112429569610284
HP:0000712HP:0000712Emotional lability0MATR3 CL E G H9782803ORPHA14506912164015
HP:0000712HP:0000712Emotional lability0MED12 CL E G H9968309520X-linked mental retardation with marfanoid habitus syndrome309520C0796022OMIM1157311957300188
HP:0000712HP:0000712Emotional lability0MTFMT CL E G H123263255241ORPHA124329666611766
HP:0000712HP:0000712Emotional lability0NDUFA10 CL E G H4705255241ORPHA14217684603835
HP:0000712HP:0000712Emotional lability0NDUFA12 CL E G H55967255241ORPHA19223987614530
HP:0000712HP:0000712Emotional lability0NDUFA13 CL E G H51079255241ORPHA16517194609435
HP:0000712HP:0000712Emotional lability0NDUFA2 CL E G H4695255241ORPHA1957685602137
HP:0000712HP:0000712Emotional lability0NDUFA4 CL E G H4697255241ORPHA1967687603833
HP:0000712HP:0000712Emotional lability0NDUFA9 CL E G H4704255241ORPHA12357693603834
HP:0000712HP:0000712Emotional lability0NDUFAF2 CL E G H91942255241ORPHA113228086609653
HP:0000712HP:0000712Emotional lability0NDUFAF5 CL E G H79133255241ORPHA138315899612360
HP:0000712HP:0000712Emotional lability0NDUFAF6 CL E G H137682255241ORPHA128128625612392
HP:0000712HP:0000712Emotional lability0NDUFS1 CL E G H4719255241ORPHA14247707157655
HP:0000712HP:0000712Emotional lability0NDUFS2 CL E G H4720255241ORPHA12477708602985
HP:0000712HP:0000712Emotional lability0NDUFS3 CL E G H4722255241ORPHA11477710603846
HP:0000712HP:0000712Emotional lability0NDUFS4 CL E G H4724255241ORPHA11397711602694
HP:0000712HP:0000712Emotional lability0NDUFS7 CL E G H374291255241ORPHA12157714601825
HP:0000712HP:0000712Emotional lability0NDUFS8 CL E G H4728255241ORPHA11297715602141
HP:0000712HP:0000712Emotional lability0NDUFV1 CL E G H4723255241ORPHA13157716161015
HP:0000712HP:0000712Emotional lability0NDUFV2 CL E G H4729255241ORPHA12297717600532
HP:0000712HP:0000712Emotional lability0NEFH CL E G H4744803ORPHA17147737162230
HP:0000712HP:0000712Emotional lability0NEK1 CL E G H4750803ORPHA16797744604588
HP:0000712HP:0000712Emotional lability0NTRK1 CL E G H4914256800Hereditary insensitivity to pain with anhidrosis256800C0020074OMIM112628031191315
HP:0000712HP:0000712Emotional lability0OPTN CL E G H10133803ORPHA142817142602432
HP:0000712HP:0000712Emotional lability0PANK2 CL E G H80025216873ORPHA149915894606157
HP:0000712HP:0000712Emotional lability0PDHA1 CL E G H5160255241ORPHA16798806300502
HP:0000712HP:0000712Emotional lability0PET100 CL E G H100131801255241ORPHA17640038614770
HP:0000712HP:0000712Emotional lability0PFN1 CL E G H5216803ORPHA11018881176610
HP:0000712HP:0000712Emotional lability0PGK1 CL E G H5230300653Phosphoglycerate kinase 1 deficiency300653C1970848OMIM13468896311800
HP:0000712HP:0000712Emotional lability0PLA2G6 CL E G H8398610217Neurodegeneration with brain iron accumulation 2b610217C1857747OMIM17759039603604
HP:0000712HP:0000712Emotional lability0POLG CL E G H5428258450Cerebellar ataxia infantile with progressive external ophthalmoplegia258450C1850303OMIM123249179174763
HP:0000712HP:0000712Emotional lability0PON1 CL E G H5444803ORPHA1659204168820
HP:0000712HP:0000712Emotional lability0PON2 CL E G H5445803ORPHA1689205602447
HP:0000712HP:0000712Emotional lability0PON3 CL E G H5446803ORPHA1629206602720
HP:0000712HP:0000712Emotional lability0PPARGC1A CL E G H10891803ORPHA1719237604517
HP:0000712HP:0000712Emotional lability0PRKACA CL E G H5566615830Pigmented nodular adrenocortical disease, primary, 4615830C4014425OMIM1439380601639
HP:0000712HP:0000712Emotional lability0PRNP CL E G H5621280397ORPHA11919449176640
HP:0000712HP:0000712Emotional lability0PRNP CL E G H5621282166ORPHA11919449176640
HP:0000712HP:0000712Emotional lability0PRNP CL E G H5621137440Gerstmann-Straussler-Scheinker syndrome137440C0017495OMIM11919449176640
HP:0000712HP:0000712Emotional lability0PRPH CL E G H5630803ORPHA1769461170710
HP:0000712HP:0000712Emotional lability0PSAP CL E G H5660309271ORPHA17729498176801
HP:0000712HP:0000712Emotional lability0SDHA CL E G H6389255241ORPHA1250310680600857
HP:0000712HP:0000712Emotional lability0SDHA CL E G H6389256000Leigh syndrome256000C0023264OMIM1250310680600857
HP:0000712HP:0000712Emotional lability0SLC19A3 CL E G H80704255241ORPHA156316266606152
HP:0000712HP:0000712Emotional lability0SLC39A4 CL E G H5563037Chromosome 3, monosomy 3pC0795806ORPHA173617129607059
HP:0000712HP:0000712Emotional lability0SLC39A4 CL E G H55630201100Hereditary acrodermatitis enteropathica201100C0221036OMIM173617129607059
HP:0000712HP:0000712Emotional lability0SLC6A19 CL E G H3400242116Encephalopathy-basal ganglia-calcificationORPHA152327960608893
HP:0000712HP:0000712Emotional lability0SLC6A19 CL E G H340024234500Neutral 1 amino acid transport defect234500C0018609OMIM152327960608893
HP:0000712HP:0000712Emotional lability0SOD1 CL E G H6647803ORPHA129411179147450
HP:0000712HP:0000712Emotional lability0SPART CL E G H23111275900Troyer syndrome275900C0393559OMIM135318514607111
HP:0000712HP:0000712Emotional lability0SQSTM1 CL E G H8878803ORPHA167711280601530
HP:0000712HP:0000712Emotional lability0SURF1 CL E G H6834255241ORPHA153211474185620
HP:0000712HP:0000712Emotional lability0SURF1 CL E G H6834256000Leigh syndrome256000C0023264OMIM153211474185620
HP:0000712HP:0000712Emotional lability0TACO1 CL E G H51204255241ORPHA111724316612958
HP:0000712HP:0000712Emotional lability0TAF15 CL E G H8148803ORPHA112511547601574
HP:0000712HP:0000712Emotional lability0TARDBP CL E G H23435803ORPHA130911571605078
HP:0000712HP:0000712Emotional lability0TARDBP CL E G H23435612069Amyotrophic lateral sclerosis type 10612069C2677565OMIM130911571605078
HP:0000712HP:0000712Emotional lability0TBK1 CL E G H29110803ORPHA138211584604834
HP:0000712HP:0000712Emotional lability0TREM2 CL E G H54209803ORPHA115417761605086
HP:0000712HP:0000712Emotional lability0UBQLN2 CL E G H29978803ORPHA127312509300264
HP:0000712HP:0000712Emotional lability0UNC13A CL E G H23025803ORPHA114023150609894
HP:0000712HP:0000712Emotional lability0VAPB CL E G H9217803ORPHA135912649605704
HP:0000712HP:0000712Emotional lability0VCP CL E G H7415803ORPHA160712666601023
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0000712HP:0000712Emotional lability0ARSA CL E G H410309263ORPHA01140713607574
HP:0000712HP:0000712Emotional lability0ARSA CL E G H410309256ORPHA01140713607574
HP:0000712HP:0000712Emotional lability0ATP1A3 CL E G H47871517ORPHA0993801182350
HP:0000712HP:0000712Emotional lability0MTPAP CL E G H55149254343ORPHA034625532613669
HP:0000712HP:0000712Emotional lability0MTPAP CL E G H55149613672Ataxia, spastic, 4, autosomal recessive613672C3150925OMIM034625532613669
HP:0000712HP:0000712Emotional lability0PSAP CL E G H5660309256ORPHA07729498176801
HP:0000712HP:0000712Emotional lability0PSAP CL E G H5660309263ORPHA07729498176801
HP:0000712HP:0000712Emotional lability0RNF168 CL E G H165918420741ORPHA035826661612688
HP:0000712HP:0000712Emotional lability0SCN8A CL E G H6334614306Cognitive impairment with or without cerebellar ataxia614306C3280415OMIM0179910596600702
HP:0000712HP:0000712Emotional lability0SPART CL E G H23111101000ORPHA035318514607111


Genes (101) :ANG ANXA11 ARSA ATP1A3 ATXN2 B4GALNT1 BCS1L C19ORF12 C19orf12 C9ORF72 C9orf72 CASR CCNF CFAP410 CHCHD10 CHMP2B COX10 COX15 CTSF DAO DCTN1 DDC ECHS1 EIF2B1 EIF2B2 EIF2B3 EIF2B4 EIF2B5 ELP1 EPHA4 ERBB4 FIG4 FOXRED1 FTL FUS GLE1 GNA11 HDAC8 HNRNPA1 LAS1L LEPR LIPT1 MATR3 MED12 MTFMT MTPAP NDUFA10 NDUFA12 NDUFA13 NDUFA2 NDUFA4 NDUFA9 NDUFAF2 NDUFAF5 NDUFAF6 NDUFS1 NDUFS2 NDUFS3 NDUFS4 NDUFS7 NDUFS8 NDUFV1 NDUFV2 NEFH NEK1 NTRK1 OPTN PANK2 PDHA1 PET100 PFN1 PGK1 PLA2G6 POLG PON1 PON2 PON3 PPARGC1A PRKACA PRNP PRPH PSAP RNF168 SCN8A SDHA SLC19A3 SLC39A4 SLC6A19 SOD1 SPART SQSTM1 SURF1 TACO1 TAF15 TARDBP TBK1 TREM2 UBQLN2 UNC13A VAPB VCP

Diseases (42) :803 309271 309263 309256 250100 71517 128235 609195 256000 124000 614298 428 255241 615362 608643 603896 223900 606159 3459 309585 179494 309520 254343 613672 256800 216873 300653 610217 258450 615830 282166 280397 137440 420741 614306 37 201100 2116 234500 101000 275900 612069
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is August 2021 release.